Maria-Luisa Maccecchini - 14 Jan 2022 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Jeffrey McGroarty, Attorney-in-Fact for Maria L. Maccecchini
Issuer symbol
ANVS
Transactions as of
14 Jan 2022
Net transactions value
+$4,614
Form type
4
Filing time
18 Jan 2022, 20:08:43 UTC
Previous filing
05 Jan 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Options Exercise $4,614 +32,959 +3.5% $0.1400* 987,734 14 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Options Exercise $0 -32,959 -38% $0.000000 52,755 14 Jan 2022 Common Stock 32,959 $0.1400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the shares underlying the option are fully vested and exercisable.